Form4insider filings, from the source

SEC Form 4 · accession 0001182489-16-000974

Nexvet Biopharma plc · NVET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
FARALLON PARTNERS L L C/CA
10% Owner · Other
Monica R Landry
10% Owner · Other
Richard B Fried
10% Owner · Other
Andrew J M Spokes
10% Owner · Other
Thomas G. Roberts Jr.
10% Owner · Other
Daniel J. Hirsch
10% Owner · Other
Michael G Linn
10% Owner · Other
David T Kim
10% Owner · Other
Michael B. Fisch
10% Owner · Other
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 5:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2,F3Feb 24, 2016P21,959$3.18A810,158D
Ordinary SharesF1,F2,F3Feb 25, 2016P20,680$3.18A830,838D
Ordinary SharesF1,F2,F3Feb 26, 2016P3,007$3.36A833,845D
Ordinary SharesF1,F2,F4Feb 24, 2016P23,681$3.18A873,720D
Ordinary SharesF1,F2,F4Feb 25, 2016P22,304$3.18A896,024D
Ordinary ShareF1,F2,F4Feb 26, 2016P3,244$3.36A899,268D
Ordinary SharesF1,F2,F5Feb 24, 2016P24,112$3.18A889,570D
Ordinary SharesF1,F2,F5Feb 25, 2016P22,710$3.18A912,280D
Ordinary SharesF1,F2,F5Feb 26, 2016P3,303$3.36A915,583D
Ordinary SharesF1,F2,F3,F7,F8Feb 24, 2016P3,213$3.18A118,540ISee Footnotes
Ordinary SharesF1,F2,F3,F7,F8Feb 25, 2016P3,026$3.18A121,566ISee Footnotes
Ordinary SharesF1,F2,F3,F7,F8Feb 26, 2016P440$3.36A122,006ISee Footnotes
Ordinary SharesF1,F2,F4,F9Feb 24, 2016P6,569$3.18A242,375ISee Footnotes
Ordinary SharesF1,F2,F4,F9Feb 25, 2016P6,187$3.18A248,562ISee Footnotes
Ordinary SharesF1,F2,F4,F9Feb 26, 2016P900$3.36A249,462ISee Footnotes
Ordinary SharesF1,F2,F5,F10Feb 24, 2016P5,519$3.18A203,623ISee Footnotes
Ordinary SharesF1,F2,F5,F10Feb 25, 2016P5,198$3.18A208,821ISee Footnotes
Ordinary SharesF1,F2,F5,F10Feb 26, 2016P756$3.36A209,577ISee Footnotes
Ordinary SharesF1,F2,F11Feb 24, 2016P54,451$3.18A2,008,910ISee Footnotes
Ordinary SharesF1,F2,F11Feb 25, 2016P51,283$3.18A2,060,193ISee Footnotes
Ordinary SharesF1,F2,F11Feb 26, 2016P7,458$3.36A2,067,651ISee Footnotes
Ordinary SharesF1,F2,F6,F12,F13Feb 24, 2016P69,752$3.18A2,573,448ISee Footnotes
Ordinary SharesF1,F2,F6,F12,F13Feb 25, 2016P65,694$3.18A2,639,142ISee Footnotes
Ordinary SharesF1,F2,F6,F12,F13Feb 26, 2016P9,554$3.36A2,648,696ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses